Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.83%185.11B | 14.21%183.59B | 11.25%50.93B | 12.94%47.61B | 20.59%45.39B | 12.75%39.66B | 6.07%160.74B | 2.72%45.78B | 11.99%42.15B | 3.22%37.64B |
| Cost of revenue | -0.82%170.25B | 15.38%171.66B | 11.53%48.12B | 11.41%43.59B | 23.39%41.79B | 16.94%38.16B | 9.04%148.77B | 4.87%43.15B | 16.11%39.12B | 4.81%33.87B |
| Gross profit | 24.59%14.86B | -0.36%11.93B | 6.74%2.81B | 32.72%4.02B | -4.50%3.6B | -40.95%1.5B | -20.76%11.97B | -23.14%2.63B | -23.12%3.03B | -9.15%3.77B |
| Operating expense | 3.94%11.4B | 2.16%10.97B | -1.02%2.81B | 6.69%2.54B | -0.58%2.73B | 4.24%2.9B | 8.91%10.74B | 16.37%2.84B | 4.07%2.38B | 7.69%2.75B |
| Operating profit | 261.17%3.46B | -22.30%958M | 98.56%-3M | 127.61%1.48B | -14.97%875M | -484.94%-1.4B | -76.51%1.23B | -121.30%-209M | -60.63%652M | -35.89%1.03B |
| Net non-operating interest income (expenses) | -95.47%-733M | -4.75%-375M | 11.11%-104M | -48.15%-120M | 24.24%-75M | -24.59%-76M | -21.36%-358M | -875.00%-117M | 19.00%-81M | -13.79%-99M |
| Non-operating interest income | -20.83%19M | 140.00%24M | ---- | ---- | ---- | ---- | -37.50%10M | ---- | ---- | ---- |
| Non-operating interest expense | 88.47%752M | 8.42%399M | 0.79%128M | 48.15%120M | -24.24%75M | 24.59%76M | 18.33%368M | 353.57%127M | -19.00%81M | 13.79%99M |
| Net investment income | -70.00%537M | 480.85%1.79B | 201.59%757M | 72.07%-369M | 396.09%379M | 40.52%1.02B | -137.30%-470M | -57.53%251M | -431.91%-1.32B | -366.67%-128M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 5,677.50%2.31B | -97.71%40M | -97.62%3M | -97.09%31M | 490.20%1.75B | -57.29%126M | 1.07B | |||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -109.49%-374M | 158.77%3.94B | -112.24%-197M | -3,650.00%-75M | 314.29%180M | 4.03B | 798.62%1.52B | 4,569.44%1.61B | 77.78%-2M | 51.45%-84M |
| Less:Other special charges | 100.46%19M | -6.40%-4.17B | 99.11%-35M | 3,650.00%75M | ---180M | ---4.03B | -8,270.83%-3.92B | -11,080.56%-3.95B | -77.78%2M | ---- |
| Less:Write off | 53.02%355M | -90.33%232M | -90.10%232M | --0 | ---- | ---- | 1,311.18%2.4B | --2.34B | --0 | ---- |
| Other non-operating income (expenses) | -147.92%-238M | -2,020.00%-96M | -1,254.55%-149M | 141.67%29M | -271.43%-12M | 1,300.00%36M | -54.55%5M | -83.33%-11M | 100.00%12M | 75.00%7M |
| Income before tax | -20.71%4.96B | 70.03%6.26B | -81.32%308M | 199.69%977M | 5.70%1.35B | 753.30%3.62B | -41.59%3.68B | -9.00%1.65B | -83.31%326M | -8.24%1.28B |
| Income tax | -23.29%1.53B | 51.52%1.99B | -84.49%105M | 388.06%327M | 16.24%458M | 531.03%1.1B | -17.43%1.31B | 149.82%677M | -88.37%67M | 7.95%394M |
| Net income | -19.51%3.44B | 80.35%4.27B | -78.99%204M | 150.00%650M | 1.13%896M | 907.60%2.52B | -49.76%2.37B | -37.03%971M | -81.10%260M | -14.15%886M |
| Net income continuous operations | -19.51%3.44B | 80.28%4.27B | -79.12%203M | 150.97%650M | 1.01%896M | 908.00%2.52B | -49.73%2.37B | -36.92%972M | -81.19%259M | -13.97%887M |
| Noncontrolling interests | -12.50%7M | 33.33%8M | -483.33%-23M | 24M | -600.00%-5M | 1,300.00%12M | 20.00%6M | 137.50%6M | 0 | -85.71%1M |
| Net income attributable to the company | -19.51%3.43B | 80.51%4.26B | -76.48%227M | 141.31%625M | 1.81%901M | 898.80%2.51B | -49.85%2.36B | -38.10%965M | -81.00%259M | -13.66%885M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.51%3.43B | 80.51%4.26B | -76.48%227M | 141.31%625M | 1.81%901M | 898.80%2.51B | -49.85%2.36B | -38.10%965M | -81.00%259M | -13.66%885M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -13.95%242.75 | 82.18%282.09 | -74.57%15.92 | 147.86%41.64 | 2.35%60.14 | 886.14%164.39 | -48.92%154.84 | -38.25%62.61 | -80.77%16.8 | -10.51%58.76 |
| Diluted earnings per share | -13.95%242.75 | 82.18%282.09 | -75.30%15.3392 | 146.29%41.3759 | 1.58%59.6468 | 886.14%164.39 | -48.92%154.84 | -38.75%62.1096 | -80.77%16.8 | -10.57%58.7169 |
| Dividend per share | 22.00%122 | 25.00%100 | 25.00%100 | 0 | 0 | 0 | 0.00%80 | 0.00%80 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |